Skip to main content
Novartis Top Menu
  • Novartis.com
Novartis Foundation LOGO
    • About Us 
      • Board of Trustees 
        • Joerg Reinhardt, Ph.D. 
        • Ann Aerts, M.D. 
        • Dr. Jo Ivey Boufford 
        • Lutz Hegemann, M.D., Ph.D. 
        • John Kahan 
        • Prof. Peter Piot, M.D. 
      • Our partners 
      Ghana telemedicine employees About Us
    • Transforming population health 
      • CARDIO4Cities 
      • AI4BetterHearts 
      • AI4HealthyCities 
        • Broadband Commission Working Group on Digital and AI in Health 
      • HealthTech Innovation 
        • Brazil COVID-19 response 
        • AI4Leprosy 
      A group of children playing outside and learning about heart health in South Africa Transforming Population Health
    • Urban Population Health Toolkit 
      • Quality of care 
      • Ensure access 
      • Policy reform 
      • Leverage data and digital 
      • Intersectoral collaboration 
      • Ensure local ownership 
      Diabetes testing in Vietnam Urban Population Health Toolkit
    • Past programs 
      • Better Hearts Better Cities 
        • Community-based Hypertension Improvement Project (ComHIP) 
        • Communities for Healthy Hearts 
        • KaziBantu (Healthy Schools for Healthy Communities) 
      • Leprosy and malaria elimination 
        • The Leprosy Alert and Response Network System (LEARNS) 
        • Leprosy Post-Exposure Prophylaxis (LPEP) program 
        • Malaria Targeted Parasite Elimination Strategy 
      • Digital Health 
        • Ghana Telemedicine 
        • Telemedicine Toolkit 
        • Integrated e-Diagnostic Approach 

      Past Programs - Mega Menu

      Patient with hypertension in hospital in Ghana Past Programs
    • Media Center 
      • News Archive  
      • Media Library  
      • Stories 
      Family participating in Leprosy Post-Exposure Prophylaxis (LPEP) Program in Nepal Media Center
    Image of three women presenting LEARNS on their mobile phones Homepage
  1. Home
  2. Media Center
  3. Media Library
  4. Evaluating the Effectiveness and Feasibility of Reactive Focal Mass Drug Administration vs. Reactive Case Detection, With and Without Reactive Vector Control, As a Community Level Intervention in Response to Confirmed, Passively Identified Malaria Cases

Evaluating the Effectiveness and Feasibility of Reactive Focal Mass Drug Administration vs. Reactive Case Detection, With and Without Reactive Vector Control, As a Community Level Intervention in Response to Confirmed, Passively Identified Malaria Cases

Back to Previous Page
Cover of ASTMH - Evaluating the effectiveness and feasibility of reactive focal mass drug administration
Description

Reactive case detection (RACD), testing and treating individuals around passively detected cases is a strategy commonly used to reduce or interrupt malaria transmission.

Evaluating the Effectiveness and Feasibility of Reactive Focal Mass Drug Administration vs. Reactive Case Detection, With and Without Reactive Vector Control, As a Community Level Intervention in Response to Confirmed, Passively Identified Malaria Cases (PDF 926.63 KB)

Related Items

  • Cover Malaria - feasibility of reactive targeted parasite elimination vs. reactive case detection
    Document
    lock
    Malaria, Publication
    Evaluating the Feasibility of Reactive Targeted Parasite Elimination vs. Reactive Case Detection, With and Without Reactive Vector Control, As a Community Level Intervention in Response to Confirmed, Passively Identified Index Cases in Zambezi Region
  • Cover of Targeted Parasite Elimination for Malaria Elimination in Namibia
    Document
    lock
    Malaria, Publication
    Targeted Parasite Elimination for Malaria Elimination in Namibia
  • Cover image of the observational study regarding child mortality patterns in rural Tanzania
    Document
    lock
    Malaria, Publication
    Child Mortality Patterns in Rural Tanzania: An Observational Study on the Impact of Malaria Control Interventions

Novartis Foundation

Navigate Novartis Foundation
  • About Us
  • Transforming Population Health
  • Urban Population Health Toolkit
  • Past Programs
About the Novartis Foundation
  • Board of Trustees
  • Our Partners
Media Center
  • News Archive
  • Media Library
  • Our Stories
Footer Bottom
© 2023 Novartis Foundation
  • Terms of Use
  • Privacy Policy
  • Cookie Settings
  • Site Map
Novartis Site Directory
This site is intended for a global audience